Publication | Open Access

Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system

Drug SafetyFda-approved Drugs BexarotenePreclinical Drug EvaluationMedicineAntiviral TherapyPharmacotherapyAntiviral DrugDrug DevelopmentPharmacologyPotential Covid-19 TreatmentsDrug Discovery